Latin America Point Of Care Infectious Disease Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
USD
1.52 Billion
USD
2.28 Billion
2024
2032
 Período de previsão |
2025 –2032 |
 Tamanho do mercado (ano base ) | USD 1.52 Billion |
 Tamanho do mercado ( Ano de previsão) | USD 2.28 Billion |
 CAGR |
% |
| Principais participantes do mercado |
Latin America Point of Care Infectious Disease Market Segmentation, By Type (Products and Services), Technology (Immunodiagnostics, Molecular Diagnostics, Dipsticks, Microfluidics and Others), Application (Tropical Diseases, Sexually Transmitted Disease, Respiratory Disorders, Liver Disorders, Inflammatory Diseases, Hospital Acquired Infections (HAIS), GI Infections, CNS Infections, Cardiovascular Infection and Others), Availability (Over-the-Counter (OTC) Testing Kits and Prescription-Based Testing Kits), End Users (Homecare Setting, Hospitals, Diagnostic Centres, Outpatient Healthcare Setting and Others), Distribution Channel (Direct Tenders and Retail Sales) - Industry Trends and Forecast to 2032
Point of Care Infectious Disease Market Analysis
Testing that may be done in close proximity to the patient and allows a medical decision to be made immediately away based on the results and monitoring is known as point-of-care testing. Doctors can examine reliable real-time, lab-quality diagnostic data in minutes rather than hours using point-of-care testing (POCT), also known as with-patient testing. It ensures that patients receive the most effective and efficient treatment available, whenever and wherever they require it.
Point of Care Infectious Disease Market Size
Latin America point of care infectious disease market size was valued at USD 1.52 billion in 2024 and is projected to reach USD 2.28 billion by 2032, with a CAGR of 5.24% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes |
Point of Care Infectious Disease Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Abbott (U.S), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S), Siemens Healthcare Private Limited (Germany), Bio-Rad Laboratories, Inc. (U.S), Danaher (U.S), Sekisui Diagnostics (U.S), Trinity Biotech (Ireland), bioMérieux (France), EKF Diagnostics (Germany), AccuBioTech Co., Ltd. (China), Instrumentation Laboratory (U.S), Beckman Coulter, Inc. (U.S), PTS Diagnostics (U.S), Nova Biomedical (U.S), Chembio Diagnostics, Inc. (U.S), Quidel Corporation (U.S) and Sienco, Inc (U.S) |
|
Market Opportunities |
|
Point of Care Infectious Disease Market Definition
Point-of-care tests are not as popular as central laboratory testing, because of their limited volume and high cost. This places additional load on the billing system, as POC testing require different codes. This could lead to billing errors by unskilled or freshly employed staff and data entry failure due to mismatched test codes in the data management system.
Point of Care Infectious Disease Market Dynamics
Drivers
- Introduction of cost-effective technology
Over the projection period, cost-effective technology for efficient and accurate disease screening, diagnosis, and monitoring, together with government initiatives to restrict disease transmission and improve healthcare facilities, is likely to be a key driver.
- Increase in geriatric population
Furthermore, an increase in the senior population, which is more susceptible to infections and other ailments, is predicted to raise demand for healthcare monitoring and diagnostic devices in home care and assisted living. In addition, the incidence of diabetes, cardiac disease, drug misuse, and STDs in developing nations and the occurrence of chronic and endemic diseases like Chagas in less developed regions is predicted to boost market potential.
- Rise in infectious diseases
As the prevalence of infectious diseases in Latin America has increased, numerous healthcare organisations and governments have implemented screening programmes and plans to control and eradicate these diseases. The Latin America point of care diagnostics market is predicted to be driven by gradually developing economies, increased spending power among the population, high disease prevalence, and increased medical knowledge over the forecast period.
Opportunities
The whole point of care infectious disease market is expected to rise in the future as healthcare and medical professionals need more automated point of care infectious disease techniques. Government initiatives and measures promoting the benefits of point-of-care infectious illness could help to increase the point-of-care infectious disease business in the coming years. The point of care infectious disease business is seeing increased demand as people become more aware of the necessity of diagnostic tests and as their disposable incomes rise.
Restraints/Challenges
- Stringent regulatory policies
The point of care testing market shows sluggish growth due to the stringent and time-consuming regulatory policies. With the expanding area of use and increased adoption in developing economies, regulators are placing a greater emphasis on point-of-care testing (POCT) compliance, safety, and usability. Point-of-care testing are classed as class II medical devices by the US Food and Drug Administration. These devices provide a reasonable guarantee of the device's effectiveness and safety.
This point of care infectious disease market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point of care infectious disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Point of Care Infectious Disease Market Scope
The point of care infectious disease market is segmented on the basis of type, technology, availability, application, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Products
- Services
Technology
- Immunodiagnostics
- Molecular Diagnostics
- Dipsticks
- Microfluidics
- Others
Application
- Tropical Diseases
- Sexually Transmitted Disease
- Respiratory Disorders
- Liver Disorders
- Inflammatory Diseases
- Hospital Acquired Infections (HAIS)
- GI Infections
- CNS Infections
- Cardiovascular Infection
- Others
Availability
- Over-the-Counter (OTC) Testing Kits
- Prescription-Based Testing Kits
End Users
- Homecare Setting
- Hospitals
- Diagnostic Centres
- Outpatient Healthcare Setting
- Others
Distribution Channel
- Direct Tenders
- Retail Sales
Point of Care Infectious Disease Market Regional Analysis
The point of care infectious disease market is analyzed and market size insights and trends are provided by country, type, technology, availability, application, distribution channel and end-user as referenced above.
The countries covered in the point of care infectious disease market report are Brazil, Argentina and Rest of South America as part of South America.
Brazil is dominating in the region due to high focus of government towards improvement of population health. The high prevalence of infectious diseases poses difficulties to authorities in achieving the goal of a healthy population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Point of Care Infectious Disease Market Share
The point of care infectious disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to point of care infectious disease market.
Point of Care Infectious Disease Market Leaders Operating in the Market Are:
- Abbott (U.S)
- F. Hoffmann-La Roche Ltd (Switzerland)
- BD (U.S)
- Siemens Healthcare Private Limited (Germany)
- Bio-Rad Laboratories, Inc. (U.S)
- Danaher (U.S)
- Sekisui Diagnostics (U.S)
- Trinity Biotech (Ireland)
- bioMérieux (France)
- EKF Diagnostics (Germany)
- AccuBioTech Co., Ltd. (China)
- Instrumentation Laboratory (U.S)
- Beckman Coulter, Inc. (U.S)
- PTS Diagnostics (U.S)
- Nova Biomedical (U.S)
- Chembio Diagnostics, Inc. (U.S)
- Quidel Corporation (U.S)
- Sienco, Inc (U.S)
Latest Developments in Point of Care Infectious Disease Market
- In March 2020, Lumiradx Limited announced a collaborative agreement with Chembio Diagnostics to develop a covid 19 virus point-of-care diagnostic test. This collaboration will aid the company in establishing a foothold in a new market
- In February 2020, Nanopin and ThermoFisher cooperated to improve infectious illness detection technologies. This partnership will give Thermofisher a new platform to expand its infectious illness point-of-care market
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
